Administration, Evaluation, and Planning Core

行政、评价和规划核心的目的是确保DANA- Farber/哈佛癌症中心(DF/HCC)前列腺癌孢子成分并提供监督 以及对孢子的科学、行政和财政方面的领导。 在DF/HCC前列腺癌孢子中，有几个层面的监督和评估。Dr。 坎托夫作为孢子主管，监督项目和核心的进展，并监督职业生涯 发展计划(与Sanda博士和D‘Amico博士一起)，发展项目计划(沿 与坎特利博士和斯坦普费尔博士)，以及所有其他拟议的活动。在DF/HCC中，Kantoff博士拥有 权威和资源，以确保这个孢子的成功。我们的治理委员会，由以下成员组成 DF/HCC前列腺癌计划的高级成员，每月开会，提供即时决定- 制作。我们有两个强大的合作伙伴。坎托夫博士将与系统教授刘易斯·坎特利博士一起出席 贝丝以色列女执事医疗中心信号转导部门的生物学和主任 作为孢子的协作者的责任。坎特利博士，自2001年以来一直是美国国家科学院院士 PO1在前列腺癌信号转导中的PI为我们带来了杰出的基础科学专业知识 程序和孢子。Meir Stampfer，医学博士，P.H.博士，营养与流行病学教授，主席， 哈佛大学公共卫生学院流行病学系也将担任联合PI。鉴于斯坦普费尔博士的 对前列腺癌的兴趣和专业知识，以及种群科学在这一孢子应用中的中心地位， 他的领导能力是受欢迎的。我们有一个强大的内部咨询委员会，由以下杰出成员组成 哈佛医学院社区和代表参与机构和主要癌症 研究学科。我们的外部咨询委员会将在五年内每年在波士顿地区举行会议 资金周期。这些委员会的成员和职能将在说明中详细讨论。 这个核心的。 管理、评估和规划核心允许提供激励智力 活动，通过研讨会和务虚会组织场地规划未来的研究，以及 对研究和支出的监督。此核心还提供与内部和外部机构合作的工具 在哈佛大学之外利用孢子的相当大的力量来筹集更多 前列腺癌的研究经费。

The purpose of the Administration, Evaluation, and Planning Core is to ensure the coordination of the Dana- Farber/Harvard Cancer Center (DF/HCC) Prostate Cancer SPORE components and to provide oversight and leadership of the scientific, administrative, and fiscal aspects of the SPORE. Within the DF/HCC Prostate Cancer SPORE, there are several layers of oversight and evaluation. Dr. Kantoff, as SPORE Director, monitors the progress of the Projects and Cores and oversees the Career Development Program (along with Drs.Sanda and D'Amico), the Developmental Projects Program (along with Drs.Cantley and Stampfer), and all other proposed activities. Within the DF/HCC, Dr. Kantoff has the authority and resources to ensure the success of this SPORE. Our Governance Committee, made up of senior members of the DF/HCC Prostate Cancer Program, meet monthly to provide immediate decision- making. We have two strong Co-Pis. Dr. Kantoff will be joined by Lewis Cantley, PhD, Professor of Systems Biology and Chief, Division of Signal Transduction at the Beth Israel Deaconess Medical Center, to assume the responsibility as Co-Pi of the SPORE. Dr. Cantley, a member of the National Academy since 2001 and the PI of a PO1 on signal transduction in prostate cancer, brings outstanding basic science expertise to our Program and SPORE. Meir Stampfer, MD, Dr.P.H., Professor of Nutrition and Epidemiology, Chair, Department of Epidemiology, Harvard School of Public Health, will also serve as Co-Pi. Given Dr. Stampfer's interest and expertise in prostate cancer and the centrality of population science in this SPORE application, his leadership is welcome. We have a strong Internal Advisory Board, comprised of prominent members of the Harvard Medical School community and representing the participating institutions and major cancer research disciplines. Our External Advisory Board will meet in the Boston area annually during the five-year funding cycle. The membership and functions of these committees are discussed in detail in the description of this Core. The Administration, Evaluation, and Planning Core allows for the provision of stimulating intellectual activities, organization of venues for planning future research through seminars and retreats, and the oversight of research and spending. This Core also provides the tools to work with institutions inside and outside of Harvard University to leverage the considerable power of the SPORE in order to raise more research funding for prostate cancer.